Bionano Genomics Inc
NASDAQ:BNGO

Watchlist Manager
Bionano Genomics Inc Logo
Bionano Genomics Inc
NASDAQ:BNGO
Watchlist
Price: 1.53 USD 2% Market Closed
Market Cap: 15.6m USD

Wall Street
Price Targets

BNGO Price Targets Summary
Bionano Genomics Inc

Wall Street analysts forecast BNGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNGO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

Lowest
Price Target
7.07 USD
362% Upside
Average
Price Target
7.65 USD
400% Upside
Highest
Price Target
8.4 USD
449% Upside
Bionano Genomics Inc Competitors:
Price Targets
OABI
OmniAb Inc
304% Upside
RVTY
Revvity Inc
19% Upside
ONESOURCE
Onesource Specialty Pharma Ltd
44% Upside
RVU
Ryvu Therapeutics SA
101% Upside
TXG
10X Genomics Inc
8% Upside
CSBR
Champions Oncology Inc
77% Upside
688046
GemPharmatech Co Ltd
39% Upside
688238
Obio Technology Shanghai Corp Ltd
56% Upside

Revenue
Forecast

Revenue Estimate
Bionano Genomics Inc

For the last 7 years the compound annual growth rate for Bionano Genomics Inc's revenue is 18%. The projected CAGR for the next 4 years is 21%.

18%
Past Growth
21%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Bionano Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Bionano Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNGO's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for BNGO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

What is Bionano Genomics Inc's Revenue forecast?
Projected CAGR
21%

For the last 7 years the compound annual growth rate for Bionano Genomics Inc's revenue is 18%. The projected CAGR for the next 4 years is 21%.

Back to Top